US IVF Services Market: Industry Analysis and Forecast (2024-2030)

  • The US IVF Services Market size was valued at USD 6012.4 Million in 2023 and the total US IVF Services revenue is expected to grow at a CAGR of 6.2% from 2024 to 2030, reaching nearly USD 9160.5 Million in 2030.

  • Format : PDF | Report ID : SMR_1588

US IVF Services Market Overview

In IVF, medical professionals actively collect eggs and sperm, combine them in a lab dish, culture fertilized embryos, and transfer the developed embryos to a woman's uterus to achieve a successful pregnancy. IVF is a widely utilized solution for infertility, benefiting couples, single mothers, and the LGBTQ+ community. The US IVF Services market's growth is driven by increased infertility rates, delayed pregnancies, technological advancements, and rising disposable incomes. The US IVF Services market is promising thanks to its large population, increased awareness, growing popularity, technological advances, and delayed pregnancies. CDC reports show high IVF success rates in the 35-39 age group, but older women face risks of genetic disorders due to incomplete egg formation and a decline in healthy egg production.


  • In 2023, a US IVF cycle costs $15,000-25,000.
  • 1 in 8 couples faces infertility.
  • Innovations like blastocyst culture and vitrification boost live birth rates by 15%.


The comprehensive report serves as a detailed analysis of the US IVF Services Market. STELLAR has precisely examined the industry's evolution, spotlighting significant trends, groundbreaking innovations, and the driving forces that mold its trajectory. Delving deep into the present landscape, the report dissects the US IVF Services Market. It accurately outlines the market's current dimensions, growth patterns, size, and the nuanced trends that use significant influence. Additionally, it keenly identifies the pivotal factors driving market growth and sheds light on growing opportunities.

US IVF Services Market

Technological Advancements and Rising Success Rates Drive the US IVF Services Market

The US IVF Services Market live birth rates exceeding 50% are achieved through breakthroughs in IVF technologies, such as improved embryo culture and advanced genetic testing marking a prominent increase. Treatment possibilities are growing through innovations such as pre-implantation genetic testing, while access is democratized through personalized protocols and cost reductions, providing hope to diverse families.





Artificial Intelligence (AI)

AI-powered embryo selection algorithms improve embryo viability and pregnancy rates. - Chatbots and virtual assistants provide personalized support and information to patients.

Increased success rates, reduced costs, and improved patient experience.

Preimplantation Genetic Testing for Aneuploidy (PGT-A)

Identifies chromosomal abnormalities in embryos before implantation, reducing the risk of miscarriage and birth defects.

Higher live birth rates, safer pregnancies, and potential for personalized embryo selection based on specific genetic traits.

Time-lapse Embryo Monitoring (Time-Lapse PGS)

Continuously monitors embryo development, providing crucial information about embryo viability and implantation potential.

Improved embryo selection, higher success rates, and potential for personalized treatment plans.

Endometrial Receptivity Array (ERA)

Analyzes gene expression in the uterine lining to determine the optimal window for embryo implantation.

Increased implantation rates, reduced need for multiple transfer cycles, personalized embryo transfer timing.


Rapid freezing technique for embryos and eggs, allowing for better preservation and storage.

Improved affordability and flexibility for IVF treatment, increased patient options.

Advanced Sperm Selection Techniques

Improve sperm quality and motility, increasing fertilization rates and pregnancy chances.

Higher success rates for couples with male infertility reduced the need for invasive procedures.

Robotic-Assisted Laparoscopy and Hysteroscopy

Minimally invasive surgery for fertility issues, reducing recovery time and potential complications.

Improved surgical outcomes, shorter hospital stays, and less pain for patients.


Additionally, rapid IVF advancements introduce ethical concerns such as designer babies, non-medical embryo selection, and potential exploitation of egg donors. Also, financial barriers persist despite cost reductions, limiting access, and raising equity concerns. Patients are often overwhelmed by the emotional toll and uncertainties of IVF. The growing US IVF Services market raises worries about exploitation through surrogacy coercion and the commodification of reproductive elements, posing ethical challenges related to informed consent and boundaries.


The US IVF services market stands at a critical juncture. Technological progress brings hope, but ethical considerations, equitable access, and patient well-being are prioritized for responsible navigation.


US IVF Services Market Segment Analysis


Based on Procedure Type, the Frozen Non-donor segment held the largest market share of about 43% in the US IVF Services Market in 2023. According to the STELLAR analysis, the segment is expected to grow at a CAGR of 6.5% during the forecast period. It stands out as the dominant segment within the US IVF Services Market thanks to its rapid technological advancement and growing adoption of smart devices with data connectivity and integration.

US IVF Services Market1

In the US IVF Services Market Using frozen embryos in IVF boosts success rates by allowing optimal uterine conditions in subsequent cycles. The approach cuts costs by eliminating the need for repeated egg retrieval and fertilization. Cryopreservation preserves fertility, assisting those facing health challenges or opting to delay childbearing. It also broadens IVF access, meeting diverse needs and providing psychological reassurance.


Additionally, the US IVF Services Market ethical concerns emerge regarding the legal status and inheritance rights of frozen embryos, underscoring the necessity for careful consideration of informed consent and embryo disposition. Also, technical challenges, such as the vitrification technique and storage conditions, affect the success of cryopreservation, presenting emotional and financial challenges for couples in case of failure. The freezing involves increased medical intervention, contributing to the complexity and cost of IVF. Psychological concerns include anxiety and distress linked to cryopreservation, while long-term storage raises logistical and financial issues. Variations in the regulatory environment across states create disparities in access and legal considerations for IVF and cryopreservation.


The US IVF market has a rise in frozen non-donor options, driven by increasing awareness, technological advancements, and shifting societal norms. Also, open communication and ethical considerations are crucial in the cryopreservation process. Additional research is vital for optimizing thawing techniques and overcoming challenges in long-term storage.

US IVF Services Market Scope

Market Size in 2023

USD 6012.4 Million

Market Size in 2030

USD 9160.4 Million

CAGR (2024-2030)


Historic Data


Base Year


Forecast Period


Segment Scope


By Procedure Type

  • Fresh Donor
  • Fresh Non-donor
  • Frozen Donor
  • Frozen Non-donor


By End-User

  • Fertility Clinics
  • Surgical Centers
  • Hospitals
  • Clinical Research Institutes


Leading Key Players in the US IVF Services Market

  • Cyprus IVF Centre
  • Dansk Fertilitetsklinik
  • Fakih IVF Fertility Center
  • Gynecology Center Monterey Bay IVF
  • Genea Oxford Fertility Limited
  • Heidelberg University Hospital
  • International Centre for Reproductive Medicine
  • IVF NAMBA Clinic
  • Morpheus Life Sciences Pvt. Ltd.
  • SAFE Fertility Center

Frequently Asked Questions

Technological Advancements and Rising Success Rates are expected to be the major drivers for the US IVF Services market.

1.    US IVF Services Market Executive Summary
1.1 Study Assumption and Market Definition
1.2 Scope of the Study
1.3 Emerging Technologies
1.4 Market Projections
1.5 Strategic Recommendations
2.    Impact of Artificial Intelligence (AI) On US IVF Services Market.
2.1 Embryo Selection and Grading
2.2 Sperm Selection and Motility Analysis
2.3 Automation and Streamlining of Processes
3.    US IVF Services Market: Dynamics
3.1.1 Market Driver
3.1.2 Market Restraints
3.1.3 Market Opportunities
3.1.4 Market Challenges

3.2 PORTER’s Five Forces Analysis
3.3 PESTLE Analysis
3.4 Regulatory Landscape 
3.5 Analysis of Government Schemes and Initiatives for the US IVF Services Industry
3.6 The Pandemic and Redefining of The US IVF Services Industry Landscape
4.    US IVF Services Market: Market Size and Forecast by Segmentation (Value) (2023-2030)
4.1 US IVF Services Market Size and Forecast, by Procedure Type (2023-2030)
4.1.1 Fresh Donor
4.1.2 Fresh Non-donor
4.1.3 Frozen Donor
4.1.4 Frozen Non-donor

4.2 US IVF Services Market Size and Forecast, End-User (2023-2030)
4.2.1 Fertility Clinics
4.2.2 Surgical Centers
4.2.3 Hospitals
4.2.4 Clinical Research Institutes

5.    US IVF Services Market: Competitive Landscape
5.1 STELLAR Competition Matrix
5.2 Competitive Landscape
5.3 Key Players Benchmarking
5.3.1 Company Name
5.3.2 Service Segment
5.3.3 End-user Segment 
5.3.4 Revenue (2023)
5.3.5 Company Locations

5.4 Leading US IVF Services Companies, by market capitalization
5.5 Market Structure
5.5.1 Market Leaders 
5.5.2 Market Followers
5.5.3 Emerging Players

5.6 Mergers and Acquisitions Details
6.    Company Profile: Key Players
6.1 Cyprus IVF Centre
6.1.1 Company Overview
6.1.2 Business Portfolio
6.1.3 Financial Overview
6.1.4 SWOT Analysis
6.1.5 Strategic Analysis
6.1.6 Scale of Operation (small, medium, and large)
6.1.7 Details on Partnership
6.1.8 Regulatory Accreditations and Certifications Received by Them
6.1.9 Awards Received by the Firm
6.1.10  Recent Developments

6.2 Dansk Fertilitetsklinik
6.4 Fakih IVF Fertility Center
6.5 Gynecology Center Monterey Bay IVF
6.6 Genea Oxford Fertility Limited
6.7 Heidelberg University Hospital
6.8 International Centre for Reproductive Medicine
6.9 IVF NAMBA Clinic
6.10 Morpheus Life Sciences Pvt. Ltd.
6.11 SAFE Fertility Center
7.     Key Findings
8.    Industry Recommendations
9.    Terms and Glossary
10.    US IVF Services Market: Research Methodology 

Enquiry Before Buy

Request Sample PDF